|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Cancer burden in the year 2000. The global picture显示文摘 | D.M Parkin F.I Bray S.S Devesa | 2001 | European Journal of Cancer2001，，： | 5 |
| 2 | Beta-blocker therapy in elderly patients with renal dysfunction and heart failure显示文摘OBJECTIVE To assess the role of beta-blockers(BB)in patients with chronic kidney disease(CKD)aged≥75 years.METHODS AND RESULTS From January 2008 to July 2014,we included 390 consecutive patients≥75 years of age with ejection fraction≤35%and glomerular filtration rate(GFR)≤60 m L/min per 1.73 m^2.We analyzed the relationship between treatment with BB and mortality or cardiovascular events.The mean age of our population was 82.6±4.1 years.Mean ejection fraction was 27.9%±6.5%.GFR was 60-45 m L/min per 1.73 m^2 in 50.3%of patients,45-30 m L/min per 1.73 m^2 in 37.4%,and<30 m L/min per 1.73 m^2 in 12.3%.At the conclusion of follow-up,67.4%of patients were receiving BB.The median follow-up was28.04(IR:19.41-36.67)months.During the study period,211 patients(54.1%)died and 257(65.9%)had a major cardiovascular event(death or hospitalization for heart failure).BB use was significantly associated with a reduced risk of death(HR=0.51,95%CI:0.35-0.74;P<0.001).Patients receiving BB consistently showed a reduced risk of death across the different stages of CKD:stage IIIa(GFR=30-45 m L/min per 1.73 m^2;HR=0.47,95%CI:0.26-0.86,P<0.0001),stage IIIb(GFR 30-45 m L/min per 1.73 m^2;HR=0.55,95%CI:0.26-1.06,P=0.007),and stages IV and V(GFR<30 m L/min per 1.73 m~2;HR=0.29,95%CI:0.11-0.76;P=0.047).CONCLUSIONS The use of BB in elderly patients with HFr EF and renal impairment was associated with a better prognosis.Use of BB should be encouraged when possible. | Juan Martínez-Milla Marcelino Cortés García Julia Anna Palfy Mikel Taibo Urquía Marta López Castillo Ana Devesa Arbiol Ana Lucía Rivero Monteagudo María Luisa Martín Mariscal Inés Jiménez-Varas Sem Briongos Figuero Juan Antonio Franco-Pelaéz JoséTuñón | 2021 | Journal of Geriatric Cardiology2021，18，1： | 3 |
| 3 | Causes and treatment of idiopathic benign paroxysmal positional vertigo based on endocrinological and other metabolic factors显示文摘The genesis of the Benign Paroxysmal Positional Vertigo(BPPV)seems to be related to some metabolic factors.These factors,such as vitamin D,glucocorticoids,and even thyroid and growth hormones,can affect bone metabolism and the mineralization of otoconia.It also seems to link to factors related to aging or nutritional habits.Besides,since the incidence of BPPV is quantitatively higher in women than in men,female sex steroids could be associated with this process.It could be useful to understand how these factors act in otoconial mineralization if we want to develop treatments aimed at preventing or delaying BPPV recurrences.In this review,we will analyze the role of these metabolic and hormonal factors in otoconial mineralization and in the treatment of BPPV. | Joaquín Guerra Jesús Devesa | 2020 | Journal of Otology2020，15，4： | 3 |
| 4 | Cancer burden in the year 2000. The global picture显示文摘 | D.M Parkin F.I Bray S.S Devesa | 2001 | European Journal of Cancer2001，，： | 3 |
| 5 | Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemi- ology, and end results program at the National Cancer Institute 显示文摘 | Hance KW Anderson WF Devesa SS | 2005 | J Natl Cancer Inst2005，97，13： | 1 |
| 6 | Calculationmethods of Structure-Soil-Structure Interaction (3SI) for embedded buildings: application to NUPEC tests 显示文摘 | Clouteau D Broc D Devesa G | 2012 | Soil Dynamics and Earthquake Engineering2012，32，1： | 1 |
| 7 | Evaluating Intangible Cultural Heritage: The Case of Cultural Festivals 显示文摘 | Barrio M J Devesa M Herrero L C | 2012 | Cit- y Culture and Society2012，3，4： | 1 |
| 8 | Non-Hodgkin's lymphoma time trends: United States and international Data显示文摘 | Devesa SS Fears R | 1992 | Cancer Res1992，52，： | 1 |
| 9 | Primary cutaneous adenoid cystic carcinoma in the United States:incidence,survival,and associated cancers,1976 to 2005显示文摘 | Dores GM Huycke MM Devesa SS | 2010 | J Am Acad Dermatol2010，63，： | 1 |
| 10 | Cancer incidence trends in urban Shanghai, 1972-1994: an update 显示文摘 | Jin F Devesa S Chow W | 1999 | Int J Cancer1999，83，： | 1 |
| 11 | Lung cancer 显示文摘 | Travis W D Travis L B Devesa S S | 1995 | Cancer1995，75，1： | 1 |
| 12 | Changing patterns in the incidence of esophageal and gastric carcinoma in the United States显示文摘 | Devesa SS Blot WJ Fraumeni JF Jr | 1998 | Cancer1998，83，10： | 1 |
| 13 | Inducers of heme oxygenase-1 显示文摘 | Ferrandiz ML Devesa I | 2008 | Curr Pharm2008，14，5： | 1 |
| 14 | Changing patterns in the incidence of esophageal and gastric carcinoma in the United States显示文摘 | Devesa SS Blot WJ Fraumeni JF Jr | 1998 | Cancer1998，83，10： | 1 |
| 15 | Growth hormone deficiency and cerebral palsy显示文摘 | Devesa J Casteleiro N Rodicio C | 2010 | Ther Clin Risk Manag2010，6，： | 1 |
| 16 | Application of column switching in high-performance liquid chromatography with on-line thermo-oxidation and detection by HGAAS and HG-AFS for the analysis of organoarsenical species in seafood samples显示文摘 | ANGELES SUNER M VICENTA DEVESA OCIEL MUNOZ | 2001 | J Anal At Spectrom2001，16，： | 1 |
| 17 | Endogenous reductants support the catalytic function of recombinant rat cyt19,an arsenic methyltransferase显示文摘 | Waters SB Devesa V Del Razo LM | 2004 | Chem Res Toxicol2004，17，3： | 1 |
| 18 | Cancer incidence trends in urban shanghai, 1972- 1994: an update 显示文摘 | Jin F Devesa SS Chow WH | 1999 | Int J Cancer1999，83，4： | 1 |
| 19 | Cancer burden in the year2000:The global picture显示文摘 | Parkin D M Bray F I Devesa S S | 2001 | Eur J Cancer2001，37，8： | 1 |
| 20 | Cancer burden in the year 2000: picture显示文摘 | Parkin Dm Bray F Devesa SS | 2001 | Eur J Cancer2001，37，8： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员